{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:37:26Z","timestamp":1787582246624,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003081","name":"Ministry of Education, Ethiopia","doi-asserted-by":"publisher","award":["2025-RISE-11-014-03"],"award-info":[{"award-number":["2025-RISE-11-014-03"]}],"id":[{"id":"10.13039\/501100003081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2026-25486352"],"award-info":[{"award-number":["RS-2026-25486352"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jconrel.2026.115040","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T23:23:34Z","timestamp":1779319414000},"page":"115040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["T cell-mediated tumor suppression by a self-amplifying mRNA-based melanoma vaccine in a syngeneic mouse model"],"prefix":"10.1016","volume":"396","author":[{"given":"Hwayoung","family":"Na","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Moo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Hyeon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Kyu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Chul","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115040_bb0005","article-title":"Melanoma brain metastases: a systematic review of opportunities for earlier detection, diagnosis, and treatment","volume":"13","author":"Diaz","year":"2023","journal-title":"Life (Basel)"},{"key":"10.1016\/j.jconrel.2026.115040_bb0010","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2023.2170095","article-title":"The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma","volume":"12","author":"Orecchini","year":"2023","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jconrel.2026.115040_bb0015","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/CM9.0000000000003416","article-title":"Recent global patterns in skin cancer incidence, mortality, and prevalence","volume":"138","author":"Wang","year":"2025","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.jconrel.2026.115040_bb0020","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaad.2024.09.035","article-title":"Global trends in melanoma burden: A comprehensive analysis from the Global Burden of Disease Study, 1990-2021","volume":"92","author":"Sun","year":"2025","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jconrel.2026.115040_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22147755","article-title":"Microbeam radiotherapy-a novel therapeutic approach to overcome radioresistance and enhance anti-tumour response in melanoma","volume":"22","author":"Trappetti","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115040_bb0030","article-title":"Advances in immunotherapy and targeted therapy of malignant melanoma","volume":"13","author":"Wang","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.jconrel.2026.115040_bb0035","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3389\/fimmu.2019.00990","article-title":"Combination of immunotherapy with targeted therapy: theory and practice in metastatic melanoma","volume":"10","author":"Yu","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115040_bb0040","doi-asserted-by":"crossref","first-page":"1155728","DOI":"10.3389\/fimmu.2023.1155728","article-title":"mRNA melanoma vaccine revolution spurred by the COVID-19 pandemic","volume":"14","author":"Xu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115040_bb0045","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1016\/j.ymthe.2022.07.007","article-title":"mRNA-LNP vaccines tuned for systemic immunization induce strong antitumor immunity by engaging splenic immune cells","volume":"30","author":"Bevers","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115040_bb0050","article-title":"Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8(+) T cell response","volume":"119","author":"Chen","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115040_bb0055","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/s41467-025-55843-9","article-title":"Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label phase I study in healthy volunteers","volume":"16","author":"Maine","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115040_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/v17040566","article-title":"Self-amplifying RNA: advantages and challenges of a versatile platform for vaccine development","volume":"17","author":"Vallet","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.jconrel.2026.115040_bb0065","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2024.5669","article-title":"mRNA vaccine development and applications: A special focus on tumors (review)","volume":"65","author":"Chen","year":"2024","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jconrel.2026.115040_bb0070","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13045-022-01247-x","article-title":"Cancer vaccines as promising immuno-therapeutics: platforms and current progress","volume":"15","author":"Liu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2026.115040_bb0075","article-title":"Cancer vaccines: antigen selection strategy","volume":"9","author":"Zhao","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jconrel.2026.115040_bb0080","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/s41417-022-00499-6","article-title":"Cancer vaccine strategies using self-replicating RNA viral platforms","volume":"30","author":"Dailey","year":"2023","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.jconrel.2026.115040_bb0085","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.ymthe.2021.04.001","article-title":"A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice","volume":"29","author":"de Alwis","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115040_bb0090","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn3464","article-title":"Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice","volume":"15","author":"Ramos da Silva","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.115040_bb0095","doi-asserted-by":"crossref","DOI":"10.1172\/JCI156211","article-title":"Messenger RNA vaccines for cancer immunotherapy: progress promotes promise","volume":"132","author":"Huff","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2026.115040_bb0100","article-title":"Lipid nanoparticle-based mRNA vaccines in cancers: current advances and future prospects","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115040_bb0105","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1039\/D2BM00883A","article-title":"mRNA-carrying lipid nanoparticles that induce lysosomal rupture activate NLRP3 inflammasome and reduce mRNA transfection efficiency","volume":"10","author":"Forster","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2026.115040_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201904905","article-title":"Mild innate immune activation overrides efficient nanoparticle-mediated RNA delivery","volume":"32","author":"Lokugamage","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115040_bb0115","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.ymthe.2023.06.017","article-title":"A localizing nanocarrier formulation enables multi-target immune responses to multivalent replicating RNA with limited systemic inflammation","volume":"31","author":"Kimura","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115040_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15061779","article-title":"The melanoma-associated antigen family A (MAGE-A): a promising target for cancer immunotherapy?","volume":"15","author":"Alsalloum","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2026.115040_bb0125","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/00000478-199808000-00007","article-title":"Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma","volume":"22","author":"Busam","year":"1998","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.jconrel.2026.115040_bb0130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00002371-200001000-00008","article-title":"Generation of T-cell immunity to a murine melanoma using MART-1-engineered dendritic cells","volume":"23","author":"Ribas","year":"2000","journal-title":"J. Immunother."},{"key":"10.1016\/j.jconrel.2026.115040_bb0135","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00002371-199701000-00002","article-title":"Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MART1 and gp100","volume":"20","author":"Zhai","year":"1997","journal-title":"J. Immunother."},{"key":"10.1016\/j.jconrel.2026.115040_bb0140","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.ymthe.2018.07.010","article-title":"A nanostructured lipid carrier for delivery of a replicating viral RNA provides single, low-dose protection against Zika","volume":"26","author":"Erasmus","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115040_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217762","article-title":"Intradermal DNA vaccination combined with dual CTLA-4 and PD-1 blockade provides robust tumor immunity in murine melanoma","volume":"14","author":"Kos","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2026.115040_bb0150","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.18632\/oncotarget.23181","article-title":"Inhibition of tumor growth by cancer vaccine combined with metronomic chemotherapy and anti-PD-1 in a pre-clinical setting","volume":"9","author":"Petrizzo","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2026.115040_bb0155","first-page":"1065","article-title":"Liposomal gp100 vaccine combined with CpG ODN sensitizes established B16F10 melanoma tumors to anti PD-1 therapy","volume":"23","author":"Yazdani","year":"2020","journal-title":"Iran J. Basic Med. Sci."},{"key":"10.1016\/j.jconrel.2026.115040_bb0160","doi-asserted-by":"crossref","first-page":"1125905","DOI":"10.3389\/fimmu.2023.1125905","article-title":"Mechanistic rationales for combining immunotherapy with radiotherapy","volume":"14","author":"Chi","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115040_bb0165","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12865-016-0172-x","article-title":"An effective cytokine adjuvant vaccine induces autologous T-cell response against colon cancer in an animal model","volume":"17","author":"Ju","year":"2016","journal-title":"BMC Immunol."},{"key":"10.1016\/j.jconrel.2026.115040_bb0170","doi-asserted-by":"crossref","first-page":"27832","DOI":"10.18632\/oncotarget.4940","article-title":"Vaccine-induced tumor regression requires a dynamic cooperation between T cells and myeloid cells at the tumor site","volume":"6","author":"Thoreau","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2026.115040_bb0175","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1615\/CritRevImmunol.v32.i2.10","article-title":"Central and effector memory CD4 and CD8 T-cell responses to tumor-associated antigens","volume":"32","author":"Caserta","year":"2012","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.115040_bb0180","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.4049\/jimmunol.1201540","article-title":"Vaccine-induced effector-memory CD8+ T cell responses predict therapeutic efficacy against tumors","volume":"189","author":"van Duikeren","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2026.115040_bb0185","doi-asserted-by":"crossref","first-page":"9571","DOI":"10.1073\/pnas.0503726102","article-title":"Central memory self\/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells","volume":"102","author":"Klebanoff","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115040_bb0190","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115040_bb0195","doi-asserted-by":"crossref","first-page":"1433185","DOI":"10.3389\/fimmu.2024.1433185","article-title":"Nucleic acid cancer vaccines targeting tumor related angiogenesis. Could mRNA vaccines constitute a game changer?","volume":"15","author":"Tadic","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115040_bb0200","article-title":"Development and delivery systems of mRNA vaccines","volume":"9","author":"Liu","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115040_bb0205","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/1097-0215(20010120)95:1<73::AID-IJC1013>3.0.CO;2-S","article-title":"Expression of Melan-A\/MART-1 antigen as a prognostic factor in primary cutaneous melanoma","volume":"95","author":"Berset","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2026.115040_bb0210","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/01.cmr.0000136713.21029.56","article-title":"Expression of Melan-A\/MART-1 in primary melanoma cell cultures has prognostic implication in metastatic melanoma patients","volume":"14","author":"Murer","year":"2004","journal-title":"Melanoma Res."},{"key":"10.1016\/j.jconrel.2026.115040_bb0215","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1084\/jem.20081382","article-title":"Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response","volume":"206","author":"Rizzuto","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2026.115040_bb0220","doi-asserted-by":"crossref","DOI":"10.4161\/onci.25032","article-title":"Boosting anticancer vaccines: too much of a good thing?","volume":"2","author":"Ricupito","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jconrel.2026.115040_bb0225","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1158\/2326-6066.CIR-21-0515","article-title":"Reversing T-cell exhaustion in cancer: lessons learned from PD-1\/PD-L1 immune checkpoint blockade","volume":"10","author":"Budimir","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jconrel.2026.115040_bb0230","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1615\/ForumImmunDisTher.2015014188","article-title":"Reinvigorating exhausted T cells by blockade of the PD-1 pathway","volume":"6","author":"Lee","year":"2015","journal-title":"For. Immunopathol. Dis. Ther."},{"key":"10.1016\/j.jconrel.2026.115040_bb0235","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.cell.2015.08.052","article-title":"Melanoma cell-intrinsic PD-1 receptor functions promote tumor growth","volume":"162","author":"Kleffel","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.115040_bb0240","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/s41590-019-0441-y","article-title":"PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1(+)CD38(hi) cells and anti-PD-1 resistance","volume":"20","author":"Verma","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2026.115040_bb0245","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.4049\/jimmunol.1100363","article-title":"Duration of antigen availability influences the expansion and memory differentiation of T cells","volume":"187","author":"Blair","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2026.115040_bb0250","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41577-024-01040-6","article-title":"A guide to adaptive immune memory","volume":"24","author":"Lam","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.115040_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102595","article-title":"Antigen-dependent interplay of formulation, systemic innate responses, and antibody responses to multi-component replicon RNA vaccination","volume":"36","author":"Kimura","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2026.115040_bb0260","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.0105-2896.2006.00391.x","article-title":"CD8+ T-cell memory in tumor immunology and immunotherapy","volume":"211","author":"Klebanoff","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jconrel.2026.115040_bb0265","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cellimm.2019.03.002","article-title":"T-memory cells against cancer: remembering the enemy","volume":"338","author":"Sarkar","year":"2019","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jconrel.2026.115040_bb0270","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12672-022-00491-4","article-title":"Cancer vaccines: past, present and future; a review article","volume":"13","author":"Grimmett","year":"2022","journal-title":"Discov. Oncol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926004438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926004438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:57:11Z","timestamp":1787579831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926004438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":54,"alternative-id":["S0168365926004438"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115040","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T cell-mediated tumor suppression by a self-amplifying mRNA-based melanoma vaccine in a syngeneic mouse model","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115040"}}